Vienna, Austria

ESTRO 2025

Session

Sunday
May 04
10:30 - 11:30
Brahms
Innovation in improving tumour radiation response
Anna Dubrovska, Germany;
Anouk Sesink, Switzerland
Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.
Proffered Papers
Radiobiology
10:30 - 10:40
Exploring the effect of radiotherapy (RT), hyperthermia (HT), and immunotherapy (IO) in head and neck squamous cell carcinoma (HNSCC)
Ifigenia Vasiliadou, United Kingdom
E25-2181
10:40 - 10:50
Enhanced radiation therapy outcomes via TGF? inhibition in the tumor microenvironment using bifunctional antibody TLX250-TRAP
Ria Kumari, USA
E25-268
10:50 - 11:00
Evaluation of individualized targeted therapy combinations in lung cancer models using a heterogeneous cohort approach to minimize animal use
Antje Dietrich, Germany
E25-962
11:00 - 11:10
SHLD2-deficient tumours display high sensitivity to DNA polymerase-theta (Polθ) inhibition combined with radiotherapy
Gonzalo Rodriguez-Berriguete, United Kingdom
E25-2821
11:10 - 11:20
Unraveling RBE variability: Distal edge effects and dose fractionation effects on acute and late damage in vivo
Cathrine Bang Overgaard, Denmark
E25-1161